Related Experiment Videos
Machine Learning Prediction of Clostridioides difficile Infection in Hospitalized COVID-19 Patients Across Pandemic
Oliver Lohaj1, Pavel Kočan1, Anna Biceková1
1Institute of Artificial Intelligence, Faculty of Electrical Engineering and Informatics, Technical University of Košice, Letná 9, 040 01 Košice, Slovakia.
Healthcare (Basel, Switzerland)
|July 15, 2026
Summary
Machine learning models effectively predict Clostridioides difficile infection (CDI) risk in hospitalized COVID-19 patients. Interpretable AI tools can aid clinical decisions, improving patient care during pandemics.
Area of Science:
- Infectious Disease Epidemiology
- Computational Medicine
- Health Informatics
Background:
- Clostridioides difficile infection (CDI) is a significant healthcare-associated complication, particularly in COVID-19 patients with prolonged hospitalization and intensive treatments.
- Antibiotic exposure and other clinical factors increase CDI risk in hospitalized populations.
Purpose of the Study:
- To develop and evaluate machine learning models for predicting CDI occurrence in hospitalized COVID-19 patients.
- To interpret these models to identify key predictors of CDI risk.
- To create a decision-support tool for clinical risk stratification.
Main Methods:
- Analysis of anonymized clinical data from 3848 COVID-19 patients using CRISP-DM methodology.
- Comparison of logistic regression, Random Forest, XGBoost, and multilayer perceptron models.
- Handling of missing data and class imbalance, with performance assessed by PR-AUC and AUROC.
- Utilizing SHAP, LIME, and odds ratio analysis for model interpretability.
Main Results:
- The best machine learning models demonstrated a significant improvement in predicting CDI risk (PR-AUC up to 0.160).
- XGBoost achieved the highest AUROC (0.823), with Random Forest also performing well (0.798).
- Inflammatory markers were identified as key predictors for CDI risk; a web-based decision-support tool was developed.
Conclusions:
- Interpretable machine learning models offer valuable CDI risk stratification for imbalanced COVID-19 datasets.
- The developed decision-support tool shows promise for clinical workflow integration.
- External and prospective validation are necessary for widespread clinical adoption.
Related Concept Videos
Steps in Outbreak Investigation
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...